| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.3 | 1e-06 |